Susquehanna International Group, LLP Day One Biopharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 64,254 shares of DAWN stock, worth $530,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,254
Previous 64,661
0.63%
Holding current value
$530,095
Previous $900,000
9.56%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$53 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$48.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$47.5 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$40.2 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$37.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $606M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...